Orange County Research Institute Enrolling Patients in Anaheim for Clinical Trial of Promising New Investigational Treatment for Alzheimer's Disease
Copyright 2022, Business Wire.
news
2022-10-17 15:00:00

ANAHEIM, Calif.--(BUSINESS WIRE)--Orange County Research Institute (OCRI) is initiating a clinical trial for a promising new investigational treatment for Alzheimer's disease (AD) in Anaheim. The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of ACU193. We are asking individuals who have memory problems to consider participating in the trial to assist in evaluating this medication for the treatment of Alzheimer's disease. There i
